Continuous glucose monitoring: Evidence and consensus statement for clinical use

Journal of Diabetes Science and Technology

Volumn 7, Issue 2, 2013, Pages 500-519

  Liebl, Andreas ^a   Henrichs, Helmut R ^b   Heinemann, Lutz ^c   Freckmann, Guido ^d   Biermann, Eberhard ^e   Thomas, Andreas ^f  

^a Hospital Bad Heilbrunn Diabetes Center Department of Internal Medicine   (Germany)

^b Working Group Diabetes Technology of the German Diabetes Association   (Germany)

^c Science and Co   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e Klinikum Schwabing   (Germany)

^f Medtronic GmbH   (Germany)

Author keywords

Clinical evidence of indications for continuous glucose monitoring; Conditions for continuous glucose monitoring use; Consensus; Continuous glucose monitoring

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

ACCURACY; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CALIBRATION; CONTINUOUS GLUCOSE MONITORING; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HYPOGLYCEMIA; INSULIN PUMP; INTERSTITIAL FLUID; METABOLIC REGULATION; PATIENT COMPLIANCE; PREGNANCY; REVIEW; SENSITIVITY AND SPECIFICITY; BLOOD; CONSENSUS; EVIDENCE BASED PRACTICE; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; PHYSIOLOGIC MONITORING; STANDARD; ANALYSIS; DIABETES MELLITUS, TYPE 1; PROCEDURES; STANDARDS;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CONSENSUS; DIABETES MELLITUS, TYPE 1; EVIDENCE-BASED PRACTICE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MONITORING, PHYSIOLOGIC; PREGNANCY;

EID: 84885973864     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700227     Document Type: Review

References (69)

1. Mauras N, Fox L, Englert K, Beck RW. Continuous glucose monitoring in type 1 diabetes. Endocrine. 2013;43(1):41-50.
2. Siegmund T, Kolassa R, Thomas A. Continuous glucose monitoring (CGM) und sensor-augmented pump therapy (SAP). London: Unimed Science Verlag Bremen; 2012.
3. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol. 1999;277(3 Pt 1):E561-71. (Pubitemid 29458218)
4. Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F. Technologies for continuous glucose monitoring: Current problems and future promises. J Diabetes Sci Technol. 2010;4(6):1540-62.
5. Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol. 2012;6(5):1060-75.
6. Mazze RS, Strock E, Stout P, Racchini J, Wesley D, Borgman S. A novel methodology to evaluate continuous glucose monitoring accuracy and clinical representation of glucose exposure and variability. Diabetes. 2007;56 Suppl 1:A107.
7. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003;26(8):2405-9. (Pubitemid 36993334)
8. Jungheim K, Koschinsky T. Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care. 2002;25(6):956-60. (Pubitemid 41110477)
9. Kovatchev BP, Shields D, Breton M. Graphical and numerical evaluation of continuous glucose sensing time lag. Diabetes Technol Ther. 2009;11(3):139-43.
10. Diabetes Research in Children Network (DIRECNET) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther. 2003;5(5):781-9.
11. Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ; Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the modified continuous glucose monitoring system (CGMS) sensor in an outpatient setting: results from a Diabetes Research in Children Network (DirecNet) study. Diabetes Technol Ther. 2005 Feb;7(1):109-14. (Pubitemid 40354580)
12. Kovatchev B, Heinemann L, Anderson S, Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care. 2008;31:1160-4.
13. Clarke WL, Anderson S, Farhy L, Breton M, Gonder-Frederick L, Cox D, Kovatchev B. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care. 2005;28(10):2412-7. (Pubitemid 41384286)
14. Garg SK, Voelmle MK, Gottlieb P. Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes. Diabetes Care. 2009;32(3):436-8.
15. Mastrototaro J, Oundararajan S, Cooper K, Shah R. Accuracy of real-time continuous glucose monitoring in the MiniMed Paradigm System. Diabetes. 2007;56 Suppl 1:A422.
16. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini J. Evaluating the accuracy, reliability, and clinical applicability of Continuous Glucose Monitoring (CGM): Is CGM ready for real time? Diabetes Technol Ther. 2009;11(1):11-8.
17. Clinical and Laboratory and Standards Institute. Performance metrics for continuous interstitial glucose monitoring; approved guideline. POCT05-A. http://shopping.netsuite.com/s.nl/c.1253739/it.A/id.413/.f.
18. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther. 2009;11(2):65-72.
19. Bailey TS, Brazg R, Cooper K, Gautham RV, Janowski R, Kaufman FR, Lee WD, Shah R, Welsh JB, Zisser H. Performance evaluation of the Medtronic MiniMed Enlite subcutaneous glucose sensor. Diabetes. 2011;60 Suppl 1:A238.
20. Nogueira K, Gautham R, Cooper K, Shah R. The Medtronic ENLITE Sensor: the next step towards fingerstick replacement. Diabetes Technol Ther. 2011;13:257.
21. Book R, Zhang T. Long term performance of a prototype 4th generation continuous glucose monitoring (CGM) device. Diabetes. 2011;60 Suppl 1:A257.
22. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-2. (Pubitemid 44912209)
23. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008;10(5):377-83.
24. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-76.
25. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378-83.
26. O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009;52(7):1250-7.
27. Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009;32(12):2245-50.
28. Hermanides J, Nørgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Fermon C, Wentholt IM, Hoekstra JB, DeVries JH. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled type 1 diabetes; a randomized controlled trial. Diabet Med. 2011;28(10):1158-67.
29. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-20.
30. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34(4):795-800.
31. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55(12):3155-62.
32. Diabetes Research in Children Network (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care. 2005;28(8):1929-35.
33. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010;12(9):679-84.
34. Gorlas S. Abrechnung der kontinuierlichen Blutzuckermessung. Dtsch Ärzteblatt. 2010;107(27):A-1374.
35. Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther. 2009;11(2):93-7.
36. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011;13(11):1129-34.
37. Pickup JC. Semi-closed-loop insulin delivery systems: Early experience with low-glucose insulin suspend pumps. Diabetes Technol Ther. 2011;13(7):695-8.
38. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011;34(9):2023-5.
39. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol. 2011;5(5):1137-41.
40. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14(3):205-9.
41. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003;111(5 Pt 1):933-8. (Pubitemid 36542603)
42. Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract. 2007;77(2):174-9. (Pubitemid 46670419)
43. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes. 2006;7(3):159-64.
44. Allen NA, Fain JA, Braun B, Chipkin SR. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract. 2008;80(3):371-9.
45. Yates K, Hasnat Milton A, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care. 2006;29(7):1512-7. (Pubitemid 44127573)
46. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, Fowler D, Campbell PJ, Temple RC. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;337:a1680.
47. Ahmet A, Dagenais S, Barrowman NJ, Collins CJ, Lawson ML. Prevalence of nocturnal hypoglycemia in pediatric Type 1 diabetes: a pilot study using continuous glucose monitoring. J Pediatr. 2011;159(2):297-302.
48. Diabetes Research In Children Network (DirecNet) Study Group, Buckingham B, Xing D, Weinzimer S, Fiallo-Scharer R, Kollman C, Mauras N, Tsalikian E, Tamborlane W, Wysocki T, Ruedy K, Beck R. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes. 2008;9(2):142-7.
49. Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith S, Nunn AJ, Manca A, Sculpher M, Barnard M, Kerr D, Weaver JU, Ahlquist J, Newman SP. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study). Diabet Med. 2009;26(5):540-7.
50. Diabetes Research in Children Network Study Group, Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes. 2009;10(2):91-6.
51. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther. 2007;9(3):203-10. (Pubitemid 46959785)
52. Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Länge K, Knip M, Danne T. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia. 2010;53(12):2487-95.
53. Danne T, de Valk HW, Kracht T, Walte K, Geldmacher R, Sölter L, von dem Berge W, Welsh ZK, Bugler JR, Lange K, Kordonouri O. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology. Diabetologia. 2009;52(8):1496-503.
54. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50. (Pubitemid 44033429)
55. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805.
56. Floyd BD, Chandra P, Hall SP, Phillips CO, Alema-Mensah E, Strayhorn G, Ofili E, Umpierrez G. Comparative analysis of the efficacy and safety of continuous glucose monitoring and self-monitoring blood glucose in type 1 diabetes mellitus. Diabetes. 2009;59 Suppl 1:A33.
57. Rys P, Mucha A, Koprowski M, Nowicki M, Malecki MT. Efficacy and safety of continuous glucose monitoring systems vs self-monitoring blood glucose in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2011;54 Suppl 1:S116.
58. Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus (Review). Cochrane Database Syst Rev. 2012;1:CD008101.
59. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care. 2012;35 Suppl 1:S11-63.
60. American Diabetes Association. Summary of revisions for the 2009 Clinical Practice Recommendations. Diabetes Care. 2009;32 Suppl 1:S3-5.
61. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 Suppl 1:1-68.
62. National Institute for Health and Clinical Excellence. Diagnosis and management of type 1 diabetes in children, young people and adults. Clinical guidelines, CG15. http://www.nice.org.uk/Guidance/CG15.
63. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008;10(4):232-46.
64. Hammond PJ, Amiel SA, Dayan CM, Kerr D, Pickup JC, Shaw JA, Campbell FM, Greene SA, Hindmarsh PC. ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care. Pract Diab Int. 2010;27:66-8.
65. Andersson M, Eliasson B, Gustafsson J, Hanas R. Guidelines for the clinical use of CGM in Sweden. Letter to Tandvårds-Och Läkemedelsförmånsverket, 2009.
66. Diabetolog Nytt. Riktlinjer för kontinuerlig mätning av vävnadsglukos vid diabetes mellitus. http://diabetolognytt.se/extra/ artikel4.html.
67. Adana MR, Rigla M. Position statement on continuous glucose monitoring. Av Diabetol. 2009;25(2):96-8.
68. Benhamou PY, Catargi B, Delenne B, Guerci B, Hanaire H, Jeandidier N, Leroy R, Meyer L, Penfornis A, Radermecker RP, Renard E, Baillot-Rudoni S, Riveline JP, Schaepelynck P, Sola-Gazagnes A, Sulmont V, Tubiana-Rufi N, Durain D, Mantovani I, Sola-Gazagnes A, Riveline JP; Société Francophone du Diabète; Société Française d'Endocrinologie; EVAluation dans le Diabète des Implants ACtifs Group. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE Diabetes Metab. 2012;38 Suppl 4:S67-83.
69. Medtronic. Professionals. http://www.medtronic-diabetes.de/fachkreise/ index.html.